Jennifer L. Sauter
Memorial Sloan Kettering Cancer Center(US)
Publications by Year
Research Areas
Occupational and environmental lung diseases, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Medical Imaging and Pathology Studies
Most-Cited Works
- → STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma(2018)1,562 cited
- → Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing(2018)1,404 cited
- → Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer(2018)1,163 cited
- → PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project(2018)795 cited
- → Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)(2018)566 cited
- → A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab(2021)531 cited
- → SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization(2020)476 cited
- → Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer(2022)337 cited
- → Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas(2020)336 cited
- → Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression(2019)333 cited